Pharma & Biotech
ANGLE’s Parsortix liquid biopsy proving to be more than just a cancer detection device
Alliance Pharma eyes pick up in momentum in second half of 2020
Motif Bio calls time on iclaprim and to become cash shell
Only registered members can use this feature.
© Proactive Investors 2021.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.